Charles River Laboratories International, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Regulation FD disclosureSep 24 →Insiders1 insider bought $4,364 in 1 open-market buy. No sales.→HoldersFMR 8.9%BlackRock 8.0%Vanguard 6.6%→PeersClosest companies: QTRX, CERT, LAB→
From the filings
Figures
- Revenue
- $4.00Blast 12 months
- Net income
- −$238.5Mlast 12 months
- Operating cash flow
- $607.0Mlast 12 months
- Cash and equivalents
- $192.0Mat the last balance sheet
- Total debt
- $2.63Bat the last balance sheet
- Shares outstanding
- 47.7M shareson issue